“I am thrilled to join Werewolf’s board of directors as the company advances its novel INDUKINE molecules through clinical development,” said Dr. Singhal. “Werewolf is demonstrating the power of the ...
Dr. Singhal is the President and Chief Executive Officer of Trishula Therapeutics, Inc., a private biotechnology company. Prior to that, Dr. Singhal served as the President and Chief Executive ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback